phenoxybenzamine has been researched along with Libman-Sacks Disease in 2 studies
Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mixed connective tissue disease is characterized by overlapping features of classic connective tissue diseases and the presence of antibodies to ribonucleoprotein." | 2.36 | Mixed connective tissue disease: an overview. ( Callen, JP, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blunt, RJ | 1 |
| Porter, JM | 1 |
| Callen, JP | 1 |
2 reviews available for phenoxybenzamine and Libman-Sacks Disease
| Article | Year |
|---|---|
Raynaud syndrome.
Topics: Adrenergic beta-Antagonists; Adult; Angiography; Antibodies, Antinuclear; Arterial Occlusive Disease | 1981 |
Mixed connective tissue disease: an overview.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Child; Cold Temperature; D | 1982 |